Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This concise practical guide is designed to facilitate the clinical decision-making process in the management of atopic dermatitis by reviewing a number of cases and defining the various diagnostic and management decisions open to clinicians. It is well illustrated and diverse in scope, enabling the reader to obtain relevant information regarding both standard and unusual cases in a rapid, easy to digest format. Each case includes a narrative description and patient management tips along with a relevant board review question. This book covers exciting updates in the diagnosis and management of…mehr
This concise practical guide is designed to facilitate the clinical decision-making process in the management of atopic dermatitis by reviewing a number of cases and defining the various diagnostic and management decisions open to clinicians. It is well illustrated and diverse in scope, enabling the reader to obtain relevant information regarding both standard and unusual cases in a rapid, easy to digest format. Each case includes a narrative description and patient management tips along with a relevant board review question. This book covers exciting updates in the diagnosis and management of AD such atopic dermatitis spectrum disorder and the effects of internal vessel inflammation in AD patients. It also highlights the newest oral, biologic and topical therapies (along with pipeline therapies) in the treatment of atopic dermatitis. Clinical Cases in Atopic Dermatitis is a must-have resource for dermatologists, dermatology residents, fellows, medical students, nurse practitioners and physician assistants, as well as allergists and immunologists.
Dr. Bhutani is dermatologist and clinical researcher in the Department of Dermatology at UCSF. She serves as co-director of the Psoriasis and Skin Treatment Center, a world-renowned clinic dedicated to the care of patients with inflammatory skin disease. Her clinical expertise includes the treatment of complex, treatment resistant cases of inflammatory skin diseases using unique combinations of topical agents, systemic treatments, biologics, and phototherapy. She also directs the Dermatology Clinical Research Unit at UCSF Dermatology, leading multiple trials aimed at learning more about what impacts inflammation in the skin and developing new and innovative treatments for skin diseases.
Dr. Liao is Professor and Vice Chair of Research in the UCSF Department of Dermatology. He serves as Co-Director of the UCSF Psoriasis and Skin Treatment Center and is deeply engaged in patient care, clinical trials, and translational research. The Liao laboratory studies the genetics and environmental triggers of inflammatory skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa.
Dr. Brownstone received a BA degree in Psychology from Cornell University and attended medical school at Rutgers Robert Wood Johnson. He trained for over 3 years as a resident in Plastic and Reconstructive Surgery before switching to a career in Dermatology. Dr. Brownstone completed a fellowship at the University of California, San Francisco Department of Dermatology in Psoriasis, Phototherapy and Clinical Research and a fellowship in melanoma at the National Society for Cutaneous Medicine/Mount Sinai Icahn School of Medicine. He is currently a Dermatology resident at Temple University Hospital in Philadelphia, Pennsylvania.
Inhaltsangabe
Chapter 1. Introduction to Atopic Dermatitis (AD).- Chapter 2. Atopic Dermatitis in Skin of Color.- Chapter 3. Atopic Dermatitis and Internal Vessel Inflammation.- Chapter 4. Atopic Dermatisis and Psychodermatology/Quality of Life.- Chapter 5. Environment and Diet.- Chapter 6. Treatment of AD with non-pharmolcogical interventions.- Chapter 7. Treatment of AD with topical therapy .- Chapter 8. Treatment of AD with Ruxolitinib.- Chapter 9. Treatment of Atopic Dermatitis with Phototherapy.- Chapter 10. Treatment of AD with Dupilumab.- Chapter 11. Ocular Co-morbidities of Atopic Conjunctivitis and Management of Conjunctivitis on Dupilumab Treatment.- Chapter 12. Management of Facial Erythema on Dupilumab treatment.- Chapter 13. Treatment of Erythrodermic Atopic Dermatitis with Cyclosporine .- Chapter 14. Treatment of AD with Tralokinumab.- Chapter 15. Treatment of AD with Abrocitinib.- Chapter 16. Treatment of AD with Upadacitnib.- Chapter 17. Treatment of Pediatric AD.- Chapter18. Atopic Dermatitis Spectrum Disorder.- Chapter 19. Infection and AD flares.- Chapter 20 Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?.- Chapter 21 Comorbidities and Atopic Dermatitis.
Chapter 1. Introduction to Atopic Dermatitis (AD).- Chapter 2. Atopic Dermatitis in Skin of Color.- Chapter 3. Atopic Dermatitis and Internal Vessel Inflammation.- Chapter 4. Atopic Dermatisis and Psychodermatology/Quality of Life.- Chapter 5. Environment and Diet.- Chapter 6. Treatment of AD with non-pharmolcogical interventions.- Chapter 7. Treatment of AD with topical therapy .- Chapter 8. Treatment of AD with Ruxolitinib.- Chapter 9. Treatment of Atopic Dermatitis with Phototherapy.- Chapter 10. Treatment of AD with Dupilumab.- Chapter 11. Ocular Co-morbidities of Atopic Conjunctivitis and Management of Conjunctivitis on Dupilumab Treatment.- Chapter 12. Management of Facial Erythema on Dupilumab treatment.- Chapter 13. Treatment of Erythrodermic Atopic Dermatitis with Cyclosporine .- Chapter 14. Treatment of AD with Tralokinumab.- Chapter 15. Treatment of AD with Abrocitinib.- Chapter 16. Treatment of AD with Upadacitnib.- Chapter 17. Treatment of Pediatric AD.- Chapter18. Atopic Dermatitis Spectrum Disorder.- Chapter 19. Infection and AD flares.- Chapter 20 Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?.- Chapter 21 Comorbidities and Atopic Dermatitis.
Chapter 1. Introduction to Atopic Dermatitis (AD).- Chapter 2. Atopic Dermatitis in Skin of Color.- Chapter 3. Atopic Dermatitis and Internal Vessel Inflammation.- Chapter 4. Atopic Dermatisis and Psychodermatology/Quality of Life.- Chapter 5. Environment and Diet.- Chapter 6. Treatment of AD with non-pharmolcogical interventions.- Chapter 7. Treatment of AD with topical therapy .- Chapter 8. Treatment of AD with Ruxolitinib.- Chapter 9. Treatment of Atopic Dermatitis with Phototherapy.- Chapter 10. Treatment of AD with Dupilumab.- Chapter 11. Ocular Co-morbidities of Atopic Conjunctivitis and Management of Conjunctivitis on Dupilumab Treatment.- Chapter 12. Management of Facial Erythema on Dupilumab treatment.- Chapter 13. Treatment of Erythrodermic Atopic Dermatitis with Cyclosporine .- Chapter 14. Treatment of AD with Tralokinumab.- Chapter 15. Treatment of AD with Abrocitinib.- Chapter 16. Treatment of AD with Upadacitnib.- Chapter 17. Treatment of Pediatric AD.- Chapter18. Atopic Dermatitis Spectrum Disorder.- Chapter 19. Infection and AD flares.- Chapter 20 Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?.- Chapter 21 Comorbidities and Atopic Dermatitis.
Chapter 1. Introduction to Atopic Dermatitis (AD).- Chapter 2. Atopic Dermatitis in Skin of Color.- Chapter 3. Atopic Dermatitis and Internal Vessel Inflammation.- Chapter 4. Atopic Dermatisis and Psychodermatology/Quality of Life.- Chapter 5. Environment and Diet.- Chapter 6. Treatment of AD with non-pharmolcogical interventions.- Chapter 7. Treatment of AD with topical therapy .- Chapter 8. Treatment of AD with Ruxolitinib.- Chapter 9. Treatment of Atopic Dermatitis with Phototherapy.- Chapter 10. Treatment of AD with Dupilumab.- Chapter 11. Ocular Co-morbidities of Atopic Conjunctivitis and Management of Conjunctivitis on Dupilumab Treatment.- Chapter 12. Management of Facial Erythema on Dupilumab treatment.- Chapter 13. Treatment of Erythrodermic Atopic Dermatitis with Cyclosporine .- Chapter 14. Treatment of AD with Tralokinumab.- Chapter 15. Treatment of AD with Abrocitinib.- Chapter 16. Treatment of AD with Upadacitnib.- Chapter 17. Treatment of Pediatric AD.- Chapter18. Atopic Dermatitis Spectrum Disorder.- Chapter 19. Infection and AD flares.- Chapter 20 Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?.- Chapter 21 Comorbidities and Atopic Dermatitis.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497